Stem-cell studies of Alzheimer's and Parkinson's head to the ISS with Axiom and the Saudi Space Agency
The National Stem Cell Foundation's neurodegeneration study launched aboard SpaceX CRS-35, adding Saudi cell lines to one of the longest-running microgravity studies of brain disease.
Researchers will study Parkinson's, primary progressive multiple sclerosis and Alzheimer's cells, evaluating how disease biology and therapeutic responses vary across diverse populations.
Microgravity lets brain organoids mature faster in space, accelerating discoveries that take much longer to emerge in ground laboratories.
King Abdullah University of Science and Technology helped prepare the Saudi samples, which join UK cell lines for early-onset Alzheimer's.
Originally reported by GlobeNewswire. Article compiled by the Deccan Age desk.